C95.02

Clinical Causes: Genetic mutations or chromosomal abnormalities Previous exposure to radiation or chemotherapy Environmental exposures (such as benzene or chemotherapy agents) Inherited genetic conditions that increase leukemia risk Family history of leukemia or other hematologic cancers Immune system disorders or suppression

Key Symptoms: Fatigue and weakness Frequent or severe infections Unexplained fevers or chills Easy bruising or bleeding Petechiae (small red or purple spots under the skin) Bone or joint pain Shortness of breath Swollen lymph nodes, liver, or spleen Unintended weight loss Night sweats

Diagnosis Path: Diagnosing this type of leukemia involves a combination of medical history, physical examination, and various tests. A blood test, known as a complete blood count (CBC), can indicate abnormal levels of blood cells. Bone marrow biopsy is essential to confirm the presence of leukemia cells and to determine the cell type. Cytogenetic studies and molecular testing help identify genetic abnormalities. Imaging tests may be performed to assess the extent of the disease, and additional tests are used to confirm relapse if the disease was previously in remission.

Treatment Protocols: Treatment strategies for acute leukemia of unspecified cell type in relapse typically involve aggressive therapy to control the disease. These may include chemotherapy to destroy leukemia cells, targeted therapy to attack specific genetic features of the cancer cells, and immunotherapy to help the immune system combat the disease. In some cases, stem cell or bone marrow transplant might be recommended, especially if the relapse is not responsive to initial treatments. Supportive care to manage symptoms and prevent infections is also a key component of treatment planning. The specific approach depends on the patient’s overall health, previous treatments, and disease characteristics.